May 13, 2025

Appendectomy Cuts UC Relapse Rates, Study

Appendicectomy may significantly reduce relapse rates within 1.

Conexiant

May 07, 2025

Pancreatitis Prevention: Just a Myth?

A major study finds no benefit from a common surgery long used to prevent pancreatitis.

Reuters

May 05, 2025

Ustekinumab Biosimilar Receives Interchangeability Approval

Selarsdi (ustekinumab-aekn) was approved by the FDA as an interchangeable biosimilar to Stelara (ustekinumab) for all approved indications, including psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis.

Conexiant

April 29, 2025

New Oral Option Approved for GCA

The FDA approved Rinvoq (upadacitinib) as the first and only oral Janus kinase inhibitor for the treatment of giant cell arteritis in adults, providing a steroid-sparing option for achieving sustained remission.

Conexiant

April 28, 2025

Oral Contraceptives Linked to Gut Gas Shifts

Researchers found oral contraceptives alter gut bacteria and breath gas levels differently depending on menstrual cycle timing.

Conexiant

April 25, 2025

Gut-Friendly Diet Linked to Lower Diabetes Risk

A study of over ten thousand US adults found that a gut-friendly diet was linked to lower risk of type 2 diabetes and insulin resistance.

Conexiant

April 24, 2025

Vitamin D Multifaceted CRC Immunomodulator Revealed

"Vitamin D enhances immune organ functions such as the spleen and lymph nodes, and boosts T-cell activity, which is essential in defending the body against tumors."

Conexiant

April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

April 18, 2025

Montelukast Effective for Ulcerative Colitis, Study

Montelukast significantly improved remission maintenance in ulcerative colitis patients during corticosteroid tapering, reducing relapse rates and inflammatory markers.

Conexiant